(Q39512233)

12 September 2017

title

Suppression of lung cancer metastasis-related protein 1 (LCMR1) inhibits the growth of colorectal cancer cells (English)

1 reference

12 September 2017

1 reference

1 reference

E Ji-Fu

1

1 reference

12 September 2017

Jun-Jie Xing

series ordinal

2

1 reference

12 September 2017

Li-Qiang Hao

series ordinal

3

1 reference

12 September 2017

Chuan-Gang Fu

series ordinal

4

1 reference

12 September 2017

publication date

6 July 2011

1 reference

Molecular Biology Reports

12 September 2017

published in

1 reference

12 September 2017

volume

39

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

3675-3681

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-011-1142-2

12 September 2017

exact match

0 references

cites work

Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Structure of eukaryotic Mediator complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

The ROX3 gene encodes an essential nuclear protein involved in CYC7 gene expression in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

The structural and functional role of Med5 in the yeast Mediator tail module

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

A functional module of yeast mediator that governs the dynamic range of heat-shock gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Overexpression of LCMR1 is significantly associated with clinical stage in human NSCLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Does RNA interference provide new hope for control of chronic hepatitis B infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Toward a durable anti-HIV gene therapy based on RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Lentiviral delivery of RNAi effectors against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

The potential of RNA interference-based therapies for viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

RNA interference screening for the discovery of oncology targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

RNAi-mediated silencing of ezrin gene reverses malignant behavior of human gastric cancer cell line SGC-7901.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

The mammalian Mediator complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-011-1142-2

siRNA and miRNA for the treatment of cancer.

21 January 2018

1 reference

12 December 2020

Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiation

1 reference

12 December 2020

Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors

1 reference

12 December 2020

Med19(Rox3) regulates Intermodule interactions in the Saccharomyces cerevisiae mediator complex.

1 reference

12 December 2020

10.1007/S11033-011-1142-2

Identifiers

DOI

1 reference

12 September 2017

1 reference